EKSO BIONICS HOLDINGS, INC.At the Market Offering Agreement • July 28th, 2023
Contract Type FiledJuly 28th, 2023This summary highlights selected information that is presented in greater detail elsewhere, or incorporated by reference, in this prospectus. It does not contain all of the information that may be important to you and your investment decision. Before investing in our securities, you should carefully read this entire prospectus, including the matters set forth under the section of this prospectus captioned “Risk Factors” and the financial statements and related notes and other information that we incorporate by reference herein, including our Annual Report on Form 10-K and our Quarterly Reports on Form 10-Q. Unless the context indicates otherwise, references in this prospectus to “Ekso,” “Ekso Bionics,” “we,” “our” and “us” refer, collectively, to Ekso Bionics Holdings,Inc., a Nevada corporation, and its subsidiaries taken as a whole.